Product name:Everolimus
CAS:159351-69-6
Molecular Formula:C53H83N1O14
Formula Weight:958.22g/mol
Description:Everolimus is a type of targeted therapy that blocks mTOR, a protein in cells that normally promotes their growth and division.It is an orally administered inhibitor of the mammalian target of rapamycin (mTOR), a therapeutic target for metastatic renal cell carcinoma. Treatment with everolimus prolongs progression-free survival relative to placebo in patients with metastatic renal cell carcinoma that had progressed on other targeted therapies.